End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36,600 KRW | -1.08% | +5.02% | +218.26% |
2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Sales * | - | Sales 1 * | - | Capitalization | 130B 94.91M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | - |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 70.22% |
1 day | -1.08% | ||
1 week | +5.02% | ||
Current month | -2.40% | ||
1 month | -0.41% | ||
3 months | +241.74% | ||
6 months | +401.37% | ||
Current year | +218.26% |
Managers | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 36,600 | -1.08% | 340,100 |
24-06-03 | 37,000 | -1.33% | 570,579 |
24-05-31 | 37,500 | -6.95% | 468,562 |
24-05-30 | 40,300 | +0.75% | 1,103,791 |
24-05-29 | 40,000 | -3.73% | 696,824 |
End-of-day quote Korea S.E., June 03, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+218.26% | 308M | |
-0.68% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- A304360 Stock